BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 16411049)

  • 1. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical variation of incidence of cutaneous melanoma in Queensland.
    Buettner PG; MacLennan R
    Aust J Rural Health; 2008 Oct; 16(5):269-77. PubMed ID: 18808484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous melanoma.
    Armstrong BK; Kricker A
    Cancer Surv; 1994; 19-20():219-40. PubMed ID: 7534627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of second primary invasive melanoma in Queensland, 1982-2003.
    McCaul KA; Fritschi L; Baade P; Coory M
    Cancer Causes Control; 2008 Jun; 19(5):451-8. PubMed ID: 18167620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the incidence of cutaneous melanoma in the west of Scotland and Queensland, Australia: hope for health promotion?
    Whiteman DC; Bray CA; Siskind V; Green AC; Hole DJ; Mackie RM
    Eur J Cancer Prev; 2008 Jun; 17(3):243-50. PubMed ID: 18414196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns.
    Youl PH; Youlden DR; Baade PD
    Br J Dermatol; 2013 Jan; 168(1):136-44. PubMed ID: 22612718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
    Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
    Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors related to the presentation of thin and thick nodular melanoma from a population-based cancer registry in Queensland Australia.
    Geller AC; Elwood M; Swetter SM; Brooks DR; Aitken J; Youl PH; Demierre MF; Baade PD
    Cancer; 2009 Mar; 115(6):1318-27. PubMed ID: 19189368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing epidemic of melanoma in the Hispanic population of California.
    Cockburn MG; Zadnick J; Deapen D
    Cancer; 2006 Mar; 106(5):1162-8. PubMed ID: 16429450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Royal Flying Doctor Service primary care skin cancer clinic: a pilot program for remote Australia.
    Scrace M; Margolis SA
    Rural Remote Health; 2009; 9(1):1048. PubMed ID: 19239334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary malignant melanoma of skin in four regions of New Zealand.
    Cooke K; McNoe B; Hursthouse M; Taylor R
    N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
    van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
    Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
    Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
    Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma of the skin in Upstate New York: recent trends and characteristics.
    Polednak AP
    Cancer Detect Prev; 1985; 8(4):485-95. PubMed ID: 4053111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thick malignant melanoma is a long-term problem.
    Asquith PR; Barnett JM; Lockett BK
    N Z Med J; 1999 Aug; 112(1094):313-6. PubMed ID: 10493441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.